Literature DB >> 10647103

Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data.

F Hefti1, G Bollini, P Dungl, J Fixsen, F Grill, E Ippolito, B Romanus, C Tudisco, S Wientroub.   

Abstract

Congenital pseudarthrosis of the tibia is a rare disease with a variable history. The pseudarthrosis is usually not present at birth (and therefore is not truly congenital) but occurs during the first decade of life. Paget in 1891 was the first to describe a case. The etiology is unknown. Neurofibromatosis plays a role in approximately 50% of patients. In the others, hereditary and mechanical factors are debated. Various (morphologic) classification systems have been proposed (Andersen, Boyd, Crawford). Because the appearance changes during the course of the disease, all classification systems have limited value: the determining factor is the stage of the disease at which it was classified. Because of the rarity of the disease and the variability of its history, the European Pediatric Orthopaedic Society decided to carry out a multicenter study on this disease. This paper presents the epidemiologic data on the patients involved. Data have been gathered on 340 patients from 13 countries. Two hundred patients were male (58.8%), 140 were female (41.2%). The right side was affected in 165 patients (48.5%) and the left side in 172 (50.6%); 3 patients had bilateral disease. Symptoms of neurofibromatosis were present in 54.7%. Histologic examinations in 192 patients showed a nonspecific appearance in 45.3%; in 15.6% the ultrastructure resembled fibrous dysplasia, and in 39% there was histologic evidence of neurofibromatosis. Most of the lesions were initially localized in the middle or distal third of the tibia. In 29% the localization changed during the course of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10647103     DOI: 10.1097/01202412-200001000-00003

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  40 in total

1.  Congenital osteofibrous dysplasia associated with pseudoarthrosis of the tibia and fibula.

Authors:  Harvey E L Teo; Wilfred C G Peh; M Akhilesh; S B Tan; T Ishida
Journal:  Skeletal Radiol       Date:  2006-08-30       Impact factor: 2.199

Review 2.  [Malformations of the lower extremities].

Authors:  F Hefti
Journal:  Orthopade       Date:  2008-04       Impact factor: 1.087

3.  Congenital pseudoarthrosis tibia with fibrous hamartoma in a child with neurofibromatosis.

Authors:  Meenu Pujani; Neha Kawatra Madan; Shailaja Shukla
Journal:  J Lab Physicians       Date:  2013-01

4.  Double inactivation of NF1 in tibial pseudarthrosis.

Authors:  David A Stevenson; Holly Zhou; Shadi Ashrafi; Ludwine M Messiaen; John C Carey; Jacques L D'Astous; Stephen D Santora; David H Viskochil
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

5.  Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia.

Authors:  Oliver Birke; Aaron Schindeler; Manoj Ramachandran; Chris T Cowell; Craig F Munns; Michael Bellemore; David G Little
Journal:  J Child Orthop       Date:  2010-10-21       Impact factor: 1.548

6.  Successful treatment of congenital pseudarthrosis of the tibia: still a challenge.

Authors:  K Bobotas; S N Lallos; V S Nikolaou; D S Kοrres; N E Efstathopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-02

7.  Congenital pseudarthrosis of the tibia: the results of an evolving protocol of management.

Authors:  N Nicolaou; A Ghassemi; R A Hill
Journal:  J Child Orthop       Date:  2013-06-12       Impact factor: 1.548

8.  Epidemiology and treatment outcome of congenital pseudarthrosis of the tibia.

Authors:  Joachim Horn; Harald Steen; Terje Terjesen
Journal:  J Child Orthop       Date:  2013-01-18       Impact factor: 1.548

9.  Congenital (infantile) pseudarthrosis of the fibula associated with osteofibrous dysplasia.

Authors:  Masanori Hisaoka; Hiroshi Hashimoto; Takayuki Ohguri; Takatoshi Aoki; Sumika Okamoto; Hidetoshi Tanaka; Nobukazu Okimoto; Toshitaka Nakamura; Tsuyoshi Ishida
Journal:  Skeletal Radiol       Date:  2004-07-16       Impact factor: 2.199

10.  Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.

Authors:  David A Stevenson; John C Carey
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-08-15       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.